Version 2024

2024 ICD-10-CM Diagnosis Code G71.02

Facioscapulohumeral muscular dystrophy

ICD-10-CM Code:
ICD-10 Code for:
Facioscapulohumeral muscular dystrophy
Is Billable?
Yes - Valid for Submission
Chronic Condition Indicator: [1]
Code Navigator:

Code Classification

  • Diseases of the nervous system
    • Diseases of myoneural junction and muscle
      • Primary disorders of muscles

G71.02 is a billable diagnosis code used to specify a medical diagnosis of facioscapulohumeral muscular dystrophy. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024.

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Autosomal dominant muscular dystrophy not predominantly limb girdle
  • Autosomal recessive muscular dystrophy not predominantly limb girdle
  • Facioscapulohumeral muscular dystrophy
  • Scapulohumeral muscular dystrophy

Clinical Classification

Clinical Information

  • Facioscapulohumeral Muscular Dystrophy

    an autosomal dominant disorder affecting the skeletal muscles of the face, scapula, and upper arm. patients present with muscle weakness in these anatomic areas. the muscle weakness eventually spreads to other skeletal muscles as well.
  • Facioscapulohumeral Muscular Dystrophy 1|FSHD1

    an autosomal dominant form of facioscapulohumeral muscular dystrophy associated with contraction of the d4z4 macrosatellite repeat.
  • Facioscapulohumeral Muscular Dystrophy 2|FSHD2

    a form of facioscapulohumeral muscular dystrophy with digenic inheritance, caused by a combination of heterozygous mutation in the smchd1 gene and the presence of a haplotype that is permissive for dux4.

Tabular List of Diseases and Injuries

The following annotation back-references are applicable to this diagnosis code. The Tabular List of Diseases and Injuries is a list of ICD-10-CM codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more.

Inclusion Terms

Inclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
  • Scapulohumeral muscular dystrophy

Index to Diseases and Injuries References

The following annotation back-references for this diagnosis code are found in the injuries and diseases index. The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10-CM code(s).

Replacement Code

G7102 replaces the following previously assigned ICD-10-CM code(s):

  • G71.0 - Muscular dystrophy

Patient Education

Muscular Dystrophy

What is muscular dystrophy (MD)?

Muscular dystrophy (MD) is a group of more than 30 genetic diseases. They cause weakness of the muscles. Over time, the weakness gets worse and can cause trouble walking and doing daily activities. Some types of MD can also affect other organs.

What are the types of muscular dystrophy (MD)?

There are many different types of MD. Some of the more common types include:

  • Duchenne muscular dystrophy, which is the most common childhood form. It is severe and affects boys more often than girls. The symptoms usually start between ages 3 and 6.
  • Becker muscular dystrophy, which is similar to Duchenne but is less severe and gets worse more slowly. It often starts in the teenage years.
  • Congenital muscular dystrophies, which are present at birth or before age 2. They can be mild or severe.
  • Facioscapulohumeral muscular dystrophy, which often starts in the teenage years. At first, it affects the muscles of the face, shoulders, and upper arms.

Each of the types of MD can be different in many ways, such as:

  • Who is more likely to get them
  • Which muscles they affect
  • When they appear, such as in infancy, childhood, middle age, or later
  • What the symptoms are
  • How serious the symptoms are
  • How quickly they get worse
  • Whether they run in families
  • Whether they affect other organs

Even within the same type of MD, people can have different symptoms.

What causes muscular dystrophy (MD)?

MD is genetic, meaning that it caused by a change in one or more genes. Gene changes are also called gene variants or mutations. The gene changes in MD affect proteins that strengthen and protect muscles.

There are different gene changes that cause each type of MD. And sometimes people who have the same type of MD can have different gene changes.

Muscular dystrophy can run in families, or you can be the first in your family to have a muscular dystrophy.

How is muscular dystrophy (MD) diagnosed?

To find out if you or your child has MD, your health care provider may use:

  • A medical and family history
  • A physical exam
  • Blood and urine tests, including genetic tests and tests for certain enzymes that may be released by damaged muscles
  • Muscle biopsies
  • Electromyography and nerve conduction studies to find out if muscles are responding the right way to nerve signals
  • Heart testing, such as an electrocardiogram (EKG), since some types of MD can cause heart problems
  • Exercise tests to measure muscle strength and breathing and detect any increased rates of certain chemicals following exercise
  • Imaging tests such as an MRI to look at muscle quality and bulk and measure fatty replacement of muscle tissue

What are the treatments for muscular dystrophy (MD)?

There is no cure for muscular dystrophy. Treatment can help with the symptoms and prevent complications. It usually includes a combination of therapies, such as:

  • Physical therapy to help keep muscles flexible and strong
  • Occupational therapy to relearn lost motor skills and learn ways to work around weakened muscles
  • Respiratory care, such as breathing exercises, oxygen therapy, and ventilators
  • Speech therapy to help with speech and swallowing problems
  • Assistive devices, such as wheelchairs, splints and braces, and walkers
  • Medicines to help delay damage to muscles or minimize the symptoms of MD
  • Surgery to treat some of the conditions associated with MD, such as heart problems, scoliosis, and cataracts

NIH: National Institute of Neurological Disorders and Stroke

[Learn More in MedlinePlus]

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019


[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.